Join Boehringer Ingelheim at a pivotal moment to shape the future of obesity and metabolic health. This is a rare launch role, where you will play a key role in shaping the launch and commercialisation of Survodutide, a next-generation therapy with the potential to redefine patient outcomes.
Working in a dynamic, cross-functional environment, you will lead end-to-end brand strategy for a pre-launch and launch asset, translating insight into action and building a focused market entry strategy in a competitive and rapidly evolving market.
Given the importance of this launch, we are seeking a candidate who can thrive in ambiguity, shape the market, and build a brand from the ground up.
This role offers strong career progression, with the opportunity to step into a future leadership position and build and lead a high-performing brand team as the franchise grows.